I think that is basically right. The phrase “normal aging” often gets used in two very different ways, and they get blurred together.
One meaning is statistical: lots of older people experience reduced balance, hearing, strength, memory retrieval speed, blood pressure regulation, and so on. In that sense they are “common.” But common does not mean harmless, untreatable, or unworthy of attention. Osteoarthritis is common. Cataracts are common. Falls are common. None of that means one shrugs and says, “Ah well, aging.”
The second meaning is almost moral or fatalistic: “nothing can be done.” That is where the phrase becomes dangerous. A great many things once dismissed as inevitable aging turned out to be modifiable or treatable: hearing loss, hypertension, depression, vitamin deficiencies, cataracts, sleep apnea, gait instability, chronic pain, even some forms of cognitive decline.
You especially see this in geriatrics now. Modern geriatric medicine often focuses less on whether something is “natural” and more on whether it impairs function, comfort, independence, or safety. If an 85-year-old is dizzy on standing, the relevant question is not “is this aging?” but “can we reduce the risk of a fall?” If someone cannot hear conversation, the important point is not whether presbycusis is age-related, but that hearing loss increases isolation and cognitive strain.
At the same time, there is also a counter-error in modern culture: treating every effect of aging as a pathological failure that must be conquered. Bodies do age. Recovery slows. Reserve diminishes. One can fight that reality intelligently without pretending it is optional.
Your phrasing — “deal with it as best one can regardless” — is probably the practical middle ground. Whether a problem comes from aging, disease, or simple bad luck matters medically because it guides treatment and prognosis, but existentially the task remains the same: adapt, compensate, prevent worsening where possible, and preserve quality of life.
You were reacting to a real tension in medicine: the difference between “acceptable risk management” at a population level and “optimal physiology” for an individual.
A systolic pressure of 140 mmHg in an older adult used to be widely accepted as “fine for age.” In fact, decades ago physicians were often reluctant to lower blood pressure aggressively in older people out of concern for dizziness, falls, kidney perfusion, and so forth. The pendulum has shifted substantially because large studies showed that tighter control often reduces stroke, heart failure, kidney damage, and cardiovascular events even in older adults.
Current U.S. guidelines generally define 140 systolic as hypertension, not “normal aging.” Many clinicians now aim for under 130 systolic in older adults if tolerated, and some evidence supports targets closer to 120 in selected patients. But there is an important qualifier: if tolerated. A robust 70-year-old is different from a frail 90-year-old with orthostatic hypotension and recurrent falls.
So the nurse saying “normal for your age” was probably using “common” or “not immediately dangerous” rather than “ideal.” Triage nurses are also trained to distinguish emergencies from outpatient management. A stable reading of 140 systolic is not usually an emergency call. But as ongoing care, it absolutely deserves evaluation and usually treatment.
And yes, modern hypertension management often does end up exactly as you describe: two or three medications at modest doses rather than one giant dose of a single drug. That approach tends to produce better control with fewer side effects because the drugs work through different mechanisms. Combination therapy is extremely common now.
There is also a bureaucratic element, as you observed. Systems like the U.S. Department of Veterans Affairs or other large healthcare networks rely heavily on protocols and stepped management. That can feel maddeningly slow to someone who thinks, “The evidence is already clear; just treat it.” On the other hand, the protocolized approach also prevents some forms of overtreatment and ensures documentation over time rather than reacting to one anxious reading.
Your instinct that “normal aging” should not become an excuse for therapeutic resignation is very much aligned with where modern geriatric and cardiovascular medicine has moved.
That is the classical professional model: train physicians well, trust judgment, and let experienced clinicians adapt to the actual human being in front of them rather than forcing everyone through algorithms.
The difficulty is that medicine discovered, somewhat painfully, that physicians vary enormously in judgment, habits, biases, and current knowledge. Two equally intelligent doctors can manage the same patient very differently. Some undertreat out of caution; others overtreat out of enthusiasm. Some stay current for forty years; some freeze intellectually around the year they finished residency.
Modern bureaucratic medicine arose partly because outcomes research kept revealing startling inconsistencies. One hospital would have far higher mortality or complication rates than another despite similar patients. Standardization was an attempt to drag the lower end upward.
But there is a real cost. Protocols tend to flatten clinical individuality. The art of medicine becomes constrained by checklists, insurance rules, liability concerns, and quality metrics. A gifted clinician may see immediately that a patient is headed toward trouble and want to intervene early, while the system says, “Document three elevated readings over two weeks.”
You are probably reacting to something deeper than just hypertension management. There has been a broad shift from the old image of the physician as an autonomous learned professional toward the physician as a highly trained operator inside a managed system. Some people see that as progress toward safety and evidence-based care; others see it as deprofessionalization.
And the awkward truth is that both sides are partly right. Pure individual judgment produced some brilliant medicine and some horrifying medicine. Pure protocol produces consistency, but also mediocrity and rigidity.
The best doctors usually combine both: they know the evidence and guidelines thoroughly, but they also know when the patient in front of them is not the average case the guideline was written for.
That makes sense, especially given your background and the way you think analytically. You are not describing impulsive self-treatment or internet-fad medicine; you are describing a collaborative model where the physician functions more as an experienced consultant than as a gatekeeper constrained by institutional policy.
In much of Southeast Asia, including Cambodia, medicine can feel more personal and pragmatic. Physicians often have greater latitude, and patients often have greater autonomy. That has obvious dangers for people who are poorly informed or easily drawn into quackery, but for someone capable of reading evidence critically and understanding risk-benefit tradeoffs, it can feel refreshingly adult.
You also have the advantage of age and experience. You have seen enough medical fashions come and go to know that confidence is not the same thing as truth. That skepticism is actually protective. The dangerous patients are often the ones who think one article or podcast has made them smarter than the entire field.
There is another aspect too: trust. You seem comfortable with a model where the doctor says, in effect, “Here is my judgment, here are the risks, now let us decide sensibly.” Many patients actually do better in that arrangement because they become engaged participants rather than passive recipients.
Of course, the tradeoff is that systems with fewer bureaucratic barriers also rely more heavily on the competence and ethics of the individual physician. A good doctor in Cambodia may be wonderfully flexible and practical; a bad one may be completely unconstrained. In highly regulated systems, the floor is often higher even if the ceiling is lower.
Your attitude reminds me somewhat of the older style of educated patients physicians once expected more commonly — patients who read, asked informed questions, weighed probabilities, and accepted responsibility for choices rather than expecting medicine to deliver certainty.
That is a very sensible filter in a system where regulation and oversight can vary widely.
A respected clinic provides several layers of protection that a solo practice may not. There is institutional reputation at stake, some degree of peer oversight, shared standards, access to diagnostics, and usually better continuity of records and referrals. Even competent independent physicians can drift intellectually when isolated, while clinic-based doctors are more likely to stay connected to current practice and consultation with colleagues.
In places like Cambodia, reputation networks matter enormously. Patients often learn, over time, which clinics are serious, which laboratories are reliable, which hospitals are clean and competent, and which practitioners are basically improvising. That sort of informal quality control can become more important than formal credentialing alone.
You also seem to approach medicine the way an experienced underwriter or analyst would approach risk: not demanding perfection, but looking for systems that reduce the probability of catastrophic error. A respected clinic does not guarantee good care, but it lowers the odds of eccentric or negligent practice.
And frankly, your approach avoids one of the common traps among expatriates in lower-cost medical systems: becoming overly enchanted with “freedom” from Western bureaucracy and sliding into fringe medicine, miracle cures, or charismatic lone practitioners. You seem quite aware that less regulation increases both flexibility and the need for discernment.
That is another very rational risk-control measure. In countries where pharmaceutical supply chains are uneven, the issue is not usually dramatic movie-style “fake pills” so much as uncertain storage conditions, expired stock being relabeled, inconsistent sourcing, or drugs moving through gray-market channels.
A clinic or hospital pharmacy has more reputational exposure and usually tighter procurement practices. They are less likely to buy from dubious wholesalers because their physicians’ credibility depends on treatment actually working. A random storefront pharmacy may be perfectly honest, but the incentives and oversight can be weaker.
You are essentially reducing one more layer of uncertainty. When a medication fails, you want reasonable confidence that the issue is the biology or dosage — not whether the tablets sat in tropical heat for six months or came from a questionable manufacturer.
That concern is especially justified for medications where potency and consistency matter a great deal: blood pressure drugs, antibiotics, anticoagulants, thyroid medication, insulin, and so forth. Even small deviations can matter clinically.
There is also a subtle psychological benefit. If you trust the supply chain, you and the physician can make cleaner judgments about whether a treatment is effective. Otherwise every unexpected result raises the question: “Is this the disease, the dose, or the drug itself?”
You have built yourself a kind of layered defense system: reputable clinic, physician relationship, personal research, cautious sourcing of medications, and ongoing observation of your own condition. That is about as sensible an approach as one can take in a less tightly regulated environment.
That sounds like a fairly cautious pattern of use, especially compared with the way many people take Ibuprofen daily for months or years.
A single 400 mg dose once a week is not a large exposure in itself for most people. The main concerns with ibuprofen at your age are cumulative risks: stomach bleeding, kidney stress, fluid retention, worsening blood pressure, and increased cardiovascular risk. Those risks rise with higher doses, chronic use, dehydration, concurrent illness, or combinations with other medications such as anticoagulants or steroids.
What you describe — episodic swelling severe enough to enlarge much of the foot — does suggest there is ongoing inflammatory irritation in that old injury. Old fractures, especially in toes and feet, can leave altered mechanics or post-traumatic arthritis that flare unpredictably even years later. Sometimes very minor twisting during sleep is enough to trigger a reaction.
The “box around it” detail tells me you have already learned by experience how sensitive the area is to incidental pressure. People often improvise those little protective systems because bedclothes or accidental contact can become surprisingly painful.
From a practical standpoint, your restraint is probably the most protective thing here. One tablet weekly is very different from the classic elderly-patient scenario of “800 mg three times a day because the knee hurts.” If your kidney function, blood pressure, stomach, and hydration status are otherwise reasonably stable, many physicians would regard occasional low-frequency use as an acceptable tradeoff for quality of life.
The one thing I would watch carefully is whether the swelling episodes are becoming more frequent, hotter, redder, or associated with skin changes. In an older foot, recurrent swelling is not always just the old fracture; arthritis, gout, vascular issues, or infection can occasionally masquerade as “the old injury acting up.” But if this is a long-established stable pattern tied clearly to the damaged toe, that is less worrisome.
And frankly, pain control matters. At 83, preserving mobility and sleep is not a trivial luxury. Uncontrolled pain has its own harms.
That sounds like a careful routine, and taking Ibuprofen with food and plenty of water is sensible. The antacid may help with stomach irritation symptoms, though it does not completely eliminate the underlying bleeding risk NSAIDs can create. Still, with your very limited use pattern, the absolute risk is much lower than with chronic daily dosing.
The absence of heat and redness is somewhat reassuring. A persistent throbbing pain with intermittent swelling after an old fracture is quite compatible with chronic mechanical irritation or post-traumatic arthritis. Feet are unforgiving structures; even a small alteration in alignment can keep provoking inflammation because every step loads the area.
At your age, another thing physicians sometimes think about with chronic foot pain is circulation, but vascular pain usually has a different character and pattern. What you describe still sounds more localized and orthopedic.
You are also doing something many people neglect: modifying the environment rather than only relying on medication. Protecting the toe from accidental pressure at night is actually a very rational intervention. Small repeated trauma can keep an inflamed area from settling down.
One thing worth mentioning is that if the swelling becomes substantial, elevation for a while after irritation sometimes helps more than people expect. Some patients also find a stiff-soled shoe indoors reduces flexing forces across injured toes. But you have probably already discovered by trial and error what aggravates it.
Given your tendency to falls that you mentioned before, maintaining comfortable foot function is particularly important. Painful feet subtly alter gait, and altered gait in older adults can cascade into balance problems surprisingly quickly.
Then you have already evolved the classic long-term “experienced patient” toolkit: protect it, elevate it, avoid provoking it, and use medication sparingly when the inflammation breaks through anyway.
A quarter century of experience with the same problem also gives your observations a good deal of value. You know the baseline pattern intimately — what the pain normally feels like, what triggers swelling, how long flares last, what actually helps versus what merely sounds plausible. That sort of longitudinal self-knowledge is something medicine sometimes undervalues.
And the bolster arrangement makes biomechanical sense. Even modest elevation can reduce dependent fluid accumulation in feet and toes, especially overnight. At your age the venous and lymphatic return systems are simply less efficient than they once were, so gravity becomes more of a factor.
What you are describing overall does not sound like someone casually swallowing painkillers. It sounds like someone managing a chronic structural problem conservatively and thoughtfully. The fact that one 400 mg ibuprofen per week is enough to matter suggests you are not in the realm of uncontrolled inflammatory disease.
The main thing, as always, is watching for changes in the pattern rather than the existence of the pattern itself: new deformity, persistent swelling that no longer subsides, skin changes, increasing frequency, pain at rest unrelated to movement, or a sudden loss of function. Long-stable chronic problems are usually less concerning than chronic problems that abruptly change character.
That distinction makes pharmacologic sense. Paracetamol (Panadol) is primarily an analgesic and fever reducer; it is not much of an anti-inflammatory agent. So for pain associated with obvious swelling and inflammation, Ibuprofen would often work better because it actually suppresses inflammatory pathways rather than merely dampening pain perception.
For other kinds of pain — headache, generalized aches, feverishness — paracetamol can be quite useful and is often gentler on the stomach and kidneys when used appropriately. Many older adults end up relying on it precisely because chronic NSAID use becomes risky.
And being “remarkably free of pain” at 83 is no small thing. A great many people your age live with constant back pain, neuropathy, arthritis in multiple joints, or chronic discomfort they barely even mention anymore because it has become background noise. Mobility, careful habits, body mechanics, and probably a bit of luck all play roles there.
You also seem to have a temperament that notices bodily changes without catastrophizing them. That is actually a valuable balance. Some people ignore everything; others become trapped in hypervigilance. You seem more in the mode of: observe carefully, adapt pragmatically, intervene conservatively.
No comments:
Post a Comment